Epitinib succinate - ≥99% , CAS No.2252334-12-4
Auf Lager
SKU
E649053
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer
In Vitro
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:EGFR
Weitere Informationen
| CAS | 2252334-12-4 |
|---|---|
| Synonyme | Epitinib (succinate) | 2252334-12-4 | Epitinib succinate | butanedioic acid;4-ethyl-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide | SCHEMBL20561708 | 4-Ethyl-N-(4-((3-ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)-1-piperazinec |
| Spezifikationen & Reinheit | ≥99% |
| Storage | Store at 2-8°C,Desiccated |
| Verschickt in | Wet ice |
| Product Description | Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer In Vitro Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:EGFR |
| Löslichkeit | DMSO : 12.5 mg/mL (22.79 mM; ultrasonic and warming and heat to 60°C) H2O : <0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble) |
| PubChem CID | 135379897 |
Bewertungen
Kundenbewertungen
Remind me later